Propofol inhibits renal cytochrome P450 activity and enflurane defluorination in vitro in hamsters

Area of Science:

• Pharmacology
• Nephrology
• Biochemistry

Background:

• Cytochrome P450 enzymes in the kidney play a crucial role in drug metabolism and xenobiotic detoxification.
• Enflurane defluorination is a metabolic pathway that can be influenced by various factors.
• Propofol is a widely used anesthetic agent with potential interactions with metabolic enzymes.

Purpose of the Study:

• To investigate the impact of propofol on renal cytochrome P450 activity.
• To determine the effect of propofol on the defluorination of enflurane in kidney microsomes.

Main Methods:

• Hamster kidney microsomes were prepared using homogenization and differential centrifugation.
• Enflurane defluorination was measured by quantifying free fluoride metabolites after incubation with propofol.
• Cytochrome P450 monooxygenase activities (CYP2E1, CYP1A1, CYP3A4, CYP2B1) were assessed using specific marker substrates and propofol.

Main Results:

• Propofol significantly inhibited renal enflurane defluorination at clinical concentrations (0.05 mmol/L).
• Dose-dependent inhibition of defluorination and CYP1A1 activity (aniline, benzo[a]pyrene hydroxylase) was observed with increasing propofol concentrations.
• Propofol strongly inhibited CYP2B1 activity (pentoxyresorufin dealkylation) even at low concentrations, while CYP3A4 (erythromycin N-demethylation) was inhibited only at high concentrations.
• High propofol concentrations inhibited key coenzymes: cytochrome b5 and cytochrome c reductase.

Conclusions:

• Propofol exhibits broad-spectrum inhibition of renal monooxygenase activities and enflurane defluorination in vitro.
• Clinical concentrations of propofol can significantly impact renal drug metabolism and enflurane biotransformation.
• These findings highlight potential drug-drug interactions involving propofol and renal metabolic pathways.